In addition, the results suggested that skeletal muscle was the most notable site of action of SFN, whose peripheral action of Nrf2 signals alleviates leptin resistance and suppresses fatty acid synthesis, leading to protection against obesity. The gene discussed is SFN; the disease is obesity due to melanocortin 4 receptor deficiency.